Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1371196 | 0.80 | TP53 (0.44) | KDM4ETAAR1MAPK1L3MBTL1 | |
| SCHEMBL1368894 | 0.77 | LPL (0.37) | KDM4E | |
| SCHEMBL1775198 | 0.77 | TRPA1 (0.44) | TAAR1TSHR | |
| SCHEMBL12680476 | 0.75 | HRH3 (1.00) | HRH3CNR2HDAC8HDAC6TAAR1 | |
| SCHEMBL1370764 | 0.75 | HSD11B1 (0.47) | KDM4ETSHR | |
| SCHEMBL27647893 | 0.74 | TDP1 (0.48) | — | |
| SCHEMBL8081767 | 0.73 | HSD11B1 (0.49) | HRH3KDM4ETSHR | |
| SCHEMBL8723594 | 0.73 | HRH3 (0.44) | HRH3CNR2HDAC8HDAC6KDM4E | |
| SCHEMBL9029706 | 0.73 | TAAR1 (0.54) | HRH3KDM4ETAAR1LTA4H | |
| SCHEMBL6609575 | 0.73 | TSHR (0.44) | LTA4HTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | claimed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | claimed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | claimed |
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-06-01 | — | — | US | disclosed |
| EP-4171490-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2023-05-03 | — | — | EP | disclosed |
| CN-115996701-A | Method for treating keratin fibres using a high concentration of a specific amino acid | 莱雅公司 | 2023-04-21 | — | — | CN | disclosed |
| WO-2022003040-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | L'OREAL (FR) | 2022-01-06 | — | — | WO | disclosed |
| WO-2017025244-A1 | COSMETIC PROCESS FOR TREATING KERATIN MATERIALS | L'OREAL (FR) | 2017-02-16 | — | — | WO | disclosed |
| WO-2017018498-A1 | COMPOSITION, PROCESS, METHOD AND USE FOR KERATIN FIBERS | L'OREAL (FR) | 2017-02-02 | — | — | WO | disclosed |
| WO-2016098870-A1 | PROCESS FOR TREATING KERATIN FIBERS TECHNICAL FIELD | L'OREAL (FR) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016076437-A1 | COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2016-05-19 | — | — | WO | disclosed |
| WO-2011089985-A1 | COSMETIC COMPOSITION FOR KERATIN FIBERS | L'OREAL (FR) | 2011-07-28 | — | — | WO | disclosed |
| EP-1598053-B1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | OREAL (FR) | 2006-12-20 | — | — | EP | disclosed |
| EP-1598053-A1 | Use of a composition containing at least one phosphine as majority reducing agent to remove the artificial colour of keratinic fibres | L'OREAL (FR) | 2005-11-23 | — | — | EP | disclosed |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | L'OREAL (FR) | 2005-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165771-A1 | PROCESS FOR TREATING KERATIN FIBERS USING PARTICULAR AMINO ACIDS IN HIGH CONCENTRATION | KRT18, CKAP4, VIM | HRH3 575/4885CNR2 4863/4885HDAC8 3008/4885 |
| US-20050251928-A1 | Method for stripping artificial color from keratin fibers | KRT18, DSG1, JUP | HRH3 294/4885CNR2 4282/4885HDAC8 590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.